FDA Alerts: Ophthalmology Drug and Device Approvals Ophthalmology Advisor FDA Category 2 Update: The 5 Peptides Still Facing Heavy Review As excitement builds around peptides potentially moving off the FDA Category 2 list, it's important to understand one key reality: Not Peptide Therapy in Austin, TX Austin Plastic Surgeon Dr. Chuma Dihexa 10mg Capsules Cognitive Research Support Peptide Pure Bio Labs FDA Tracker for Cell and Gene Therapies in 2026 Alliance for Regenerative Medicine posted on the topic LinkedIn A federal review is underway that could reclassify 14 peptides into FDA Category 1. This change that may influence how peptide therapies are accessed in the U.S. Here's what experts are